Welcome to the e-CCO Library!

P0414: Serum Activin-A level as a new biomarker in active Ulcerative Colitis patients
Year: 2025
Source: ECCO'25
Authors: Ayyildizx7x7x7 T.(1)*;Ketencix7x7x7 Y.B.(2);Duygulux7x7x7 M.E.(3);Zorlux7x7x7 B.Ş.(4);Avcıx7x7x7 B.(5);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0415: Bone turnover biomarkers alteration in patients with Inflammatory Bowel Disease.
Year: 2025
Source: ECCO'25
Authors: Omranx7x7x7 S.(1)*;Gamal Eldeenx7x7x7 H.(1);Abdel Latifx7x7x7 Z.(1);Abdoux7x7x7 D.(2);Hamdyx7x7x7 R.(3);Gaberx7x7x7 A.(1);Alix7x7x7 A.(1);Shehabx7x7x7 H.(1);El Razikyx7x7x7 M.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0416: Efficacy and safety of oral sulphate tablet for bowel preparation in patients with moderate to severe ulcerative colitis: a multicenter cohort study
Year: 2025
Source: ECCO'25
Authors: Songx7x7x7 J.H.(1)*;Shinx7x7x7 J.(2);Kongx7x7x7 S.M.(3);Chax7x7x7 B.(4);Hongx7x7x7 J.T.(4);Kwonx7x7x7 K.S.(4);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0417: Impact of Cytomegalovirus infection on patients with Inflammatory Bowel Disease in the Southern Area of Gran Canaria: a case-control study.
Year: 2025
Source: ECCO'25
Authors: Peñate BolañosPhDx7x7x7 M.(1)*;Tosco-Nuñezx7x7x7 T.(2);Hernández Expósitox7x7x7 N.(1);Rodríguez Castellotx7x7x7 J.(1);Ciordia Naldax7x7x7 I.(1);Alemán Gonzalezx7x7x7 H.(1);Quevedo Ruanox7x7x7 R.(3);Monescillo Franciax7x7x7 A.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0418: The implementation of IBD-dedicated multidisciplinary healthcare pathway improves patients’ satisfaction and reduces disability in patients with IBD
Year: 2025
Source: ECCO'25
Authors: Buissonx7x7x7 A.(1)*;Banana Hamadidix7x7x7 A.(1);Dumasx7x7x7 V.(1);Dodelx7x7x7 M.(1);Cobanx7x7x7 D.(1);Bazogex7x7x7 M.(1);Rivièrex7x7x7 C.(1);Heuxx7x7x7 J.(1);Pereirax7x7x7 B.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0419: Impact of psychopathology and gut-microbiota on disease progression in Ulcerative Colitis: a five-year follow-up study
Year: 2025
Source: ECCO'25
Authors: D'Onofriox7x7x7 A.M.(1);Chierax7x7x7 E.(2)*;Gomez-Nguyenx7x7x7 A.(3);Di Vincenzox7x7x7 F.(4);Spagnolox7x7x7 G.(5);Ferraresex7x7x7 D.(5);Cammarotax7x7x7 G.(4);Camardesex7x7x7 G.(1);Scaldaferrix7x7x7 F.(4);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P041: Automated image analysis as a diagnostic tool in discriminating between subgroups of microscopic colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A.-M. Kanstrup-Fiehn1, M. Kristensson2, U. H. Engel3, L. K. Munck4, 5, 
S. Holck3, P. J. H. Engel*1, 5

Created: Friday, 22 February 2019, 9:49 AM
P041: C-jun n-terminal kinase 2 promotes enterocyte survival and goblet cell differentiation in the inflamed intestine
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mandić A.D.1, Bennek E.1, Verdier J.1, Zhang K.2, Roubrocks S.1, Davis R.J.3, Denecke B.4, Gassler N.5, Streetz K.6, Kel A.7, Hornef M.2, Cubero F.J.1, Trautwein C.1, Sellge G.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P041: CDKN2B-AS1 (ANRIL) expression is decreased in Inflammatory Bowel Disease epithelia and in Celiac, and its reduction is linked with induced cells proliferation
Year: 2021
Source: ECCO'21 Virtual
Authors: Benshoshan, M.(1);Sosnovski, K.E.(1);Braun, T.(2);Amir, A.(2);Anikster, Y.(2);Haberman Ziv, Y.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P041: Characterization of cytokine and drug concentrations in serum, mucosa and faeces during induction treatment of moderate-to-severe ulcerative colitis with anti-TNF monoclonal antibodies
Year: 2022
Source: ECCO'22
Authors: Van Oostrom, J.(1);Hanzel, J.(1,2);Verstockt, B.(3,4);Singh, S.(5);Smith, J.(5);Stylli, J.(5);Vermeire, S.(3);D'Haens, G.(1);
Created: Friday, 11 February 2022, 3:52 PM
P041: Differences in NOTCH signalling between stricturing and penetrating behaviour in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Rodriguez-Antequera1, J. Cosin-Roger2,3, D. Macias-Ceja3, P. Salvador4, L. Gisbert-Ferrándiz4, S. Coll4, J. Manyé5, R. Alós6, F. Navarro-Vicente7, S. Calatayud2,4, M. D. Barrachina2,4, D. Ortiz-Masia1,2

Created: Friday, 22 February 2019, 9:41 AM
P041: Targeting fibroblast activation protein in Crohn’s disease intestinal strictures restores balanced deposition of extracellular matrix and reduces fibrosis
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Truffi1*, L. Sorrentino1, M. Monieri1, S. Mazzucchelli1, P. Fociani2, G.M. Sampietro3, A. Di Sabatino4, F. Corsi1,5

Created: Thursday, 21 February 2019, 9:14 AM
P041: The upregulation of tissue factor in colonic mesenchymal cells in active ulcerative colitis is associated with severe and resistant to treatment disease, but tofacitinib has not effect on it
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Drygiannakis, I.(1)*;Tzenaki, N.(1);Archontoulaki, E.(2);Filidou, E.(3);Kandilogiannakis, L.(3);Valatas, V.(1);Kolios, G.(3);Koutroubakis, I.E.(1);
Created: Friday, 14 July 2023, 10:48 AM
P042 Patient perspective on the impact of complex perianal fistulas in Crohn’s disease on quality of life: introducing the concept of the patient survey conducted in Europe
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Spinelli1, S. Lönnfors2, L. Avedano2, D. Bojic3

Created: Thursday, 30 January 2020, 10:12 AM
P0420: Interim analysis of real-world-data on PROs and biomarker remission collected through the Health Outcome Observatory (H2O) consortium in IBD patients
Year: 2025
Source: ECCO'25
Authors: Novacekx7x7x7 G.(1)*;Fierensx7x7x7 L.(2);Primasx7x7x7 C.(1);Ferrantex7x7x7 M.(2);Schreinerx7x7x7 P.(1);Borruelx7x7x7 N.(3);Serrax7x7x7 X.(3);Dabschx7x7x7 S.(1);Schillingx7x7x7 V.(1);Frickx7x7x7 A.(1);Reinischx7x7x7 W.(1);Schweigerx7x7x7 K.(1);Galanx7x7x7 G.(4);Ferrix7x7x7 M.(4);Ritschlx7x7x7 V.(5);Mosorx7x7x7 E.(5);Longx7x7x7 P.(5);Winklerx7x7x7 E.(1);Mooslechnerx7x7x7 T.(1);Wisniowskix7x7x7 K.(1);Kazemi-Shirazix7x7x7 L.(1);Bäuerlex7x7x7 M.(1);Dejacox7x7x7 C.(1);Stammx7x7x7 T.(5);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0421: Clinical validity of a seroproteomic index of endoscopic activity in pediatric Crohn's disease
Year: 2025
Source: ECCO'25
Authors: Orlanski Meyer x7x7x7 E.(1);Dotson x7x7x7 J.(2);Saeed x7x7x7 S.(3);Zitomersky x7x7x7 N.(4);Focht x7x7x7 G.(1)*;Rabizadeh x7x7x7 S.(5);Sockolow x7x7x7 R.(6);Griffiths x7x7x7 A.(7);Navas-López x7x7x7 V.M.(8);Sladek x7x7x7 M.(9);Baldassano x7x7x7 R.(10);Otley x7x7x7 A.(11);Spencer x7x7x7 E.(12);Ho x7x7x7 J.(13);Dervieux x7x7x7 T.(13);Turner x7x7x7 D.(1);Dubinsky x7x7x7 M.(12);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0422: CROHN-PREP study: Simplified bowel preparation adapted to small bowel capsule endoscopy in patients with Crohn’s disease; comparison with the reference method.
Year: 2025
Source: ECCO'25
Authors: Rouveyrex7x7x7 R.(1)*;Collinsx7x7x7 M.(1);De Maissinx7x7x7 A.(2);Flamantx7x7x7 M.(1x7x7x73);Trangx7x7x7 C.(1x7x7x74);Bouguenx7x7x7 G.(5);Dibx7x7x7 N.(6);Bourreillex7x7x7 A.(1);Le Berrex7x7x7 C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0423: Anastomotic leakage after ileoanal pouch surgery: risk factors and salvage
Year: 2025
Source: ECCO'25
Authors: Moojenx7x7x7 T.(1)*;Vlugx7x7x7 M.(1);Visserx7x7x7 E.(1);Reijntjesx7x7x7 M.(1);Langex7x7x7 J.(2);Bislenghix7x7x7 G.(3);Carvellox7x7x7 M.(4);Warusavitarnex7x7x7 J.(5);Hompesx7x7x7 R.(1);Stassenx7x7x7 L.(6);Faizx7x7x7 O.(5);Spinellix7x7x7 A.(4);D'Hoorex7x7x7 A.(3);Bemelmanx7x7x7 W.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0424: Utility of superb microvascular imaging for predicting terminal ileal lesion activity in Crohn’s disease
Year: 2025
Source: ECCO'25
Authors: Nasunox7x7x7 M.(1)*;Shimoyamax7x7x7 K.(1);Hamadax7x7x7 T.(1);Shimazakix7x7x7 H.(1);Sugiyamax7x7x7 K.(1x7x7x72);Miyakawax7x7x7 M.(1);Tanakax7x7x7 H.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0425: Factors Associated with Biopsy-Proven Cuffitis in Ulcerative Colitis Patients Following Colectomy with Ileal Anal-Pouch Anastomosis
Year: 2025
Source: ECCO'25
Authors: Fishmanx7x7x7 M.(1);Codishx7x7x7 M.(2);Rabinowitzx7x7x7 K.(1);Avni-Bironx7x7x7 I.(1);Godnyx7x7x7 L.(1);Yanaix7x7x7 H.(1);Dotanx7x7x7 I.(1);Ollechx7x7x7 J.(3)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session